Literature DB >> 2869320

Teicoplanin-induced ototoxicity in Down's syndrome.

E R Maher, A Hollman, R N Grüneberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869320     DOI: 10.1016/s0140-6736(86)92830-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.

Authors:  A Webster; A P Wilson; A H Williams; T Treasure; R N Grüneberg
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

Review 2.  A risk-benefit assessment of teicoplanin in the treatment of infections.

Authors:  F de Lalla; A Tramarin
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

3.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 4.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.